Document Classification

Section Type: RESULTS

Text: Triamcinolone acetonide treatment resulted in improvement from baseline of 17 % for FEV1 (P <. 0001) ; 44 % for albuterol use (P =. 0009) ; 9 % for FVC (P =. 0185) ; 19 % for PEF (P =. 0011) ; 42 % for FEF25-75 % (P <. 0001) ; 8 % for FEV1/FVC (P =. 0016) ; 36 % for daytime, 39 % for nighttime, and 38 % for total asthma symptoms (P < or =. 0001) ; and 12 % for morning, and 10 % for evening PEF (P < or =. 001).